BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32540433)

  • 21. Advances in targeting 'undruggable' transcription factors with small molecules.
    Henley MJ; Koehler AN
    Nat Rev Drug Discov; 2021 Sep; 20(9):669-688. PubMed ID: 34006959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of post-translational modifications in histone proteins: A review on histone modification defects in developmental and neurological disorders.
    Ramazi S; Allahverdi A; Zahiri J
    J Biosci; 2020; 45():. PubMed ID: 33184251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of transcription factors by sumoylation.
    Rosonina E; Akhter A; Dou Y; Babu J; Sri Theivakadadcham VS
    Transcription; 2017 Aug; 8(4):220-231. PubMed ID: 28379052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review of Post-translational Modification of Human Serum Albumin.
    Kannan S; Souchelnytskyi S
    Curr Protein Pept Sci; 2022; 23(2):114-120. PubMed ID: 35176988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drugging the 'undruggable'. Therapeutic targeting of protein-DNA interactions with the use of computer-aided drug discovery methods.
    Radaeva M; Ton AT; Hsing M; Ban F; Cherkasov A
    Drug Discov Today; 2021 Nov; 26(11):2660-2679. PubMed ID: 34332092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of post-translational modifications in cardiac hypertrophy.
    Yan K; Wang K; Li P
    J Cell Mol Med; 2019 Jun; 23(6):3795-3807. PubMed ID: 30950211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-translational and transcriptional dynamics - regulating  extracellular vesicle biology.
    Claridge B; Kastaniegaard K; Stensballe A; Greening DW
    Expert Rev Proteomics; 2019 Jan; 16(1):17-31. PubMed ID: 30457403
    [No Abstract]   [Full Text] [Related]  

  • 28. Targeting transcription factors in cancer - from undruggable to reality.
    Bushweller JH
    Nat Rev Cancer; 2019 Nov; 19(11):611-624. PubMed ID: 31511663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deciphering the Role of the Ser-Phosphorylation Pattern on the DNA-Binding Activity of Max Transcription Factor Using Chemical Protein Synthesis.
    Nithun RV; Yao YM; Lin X; Habiballah S; Afek A; Jbara M
    Angew Chem Int Ed Engl; 2023 Nov; 62(47):e202310913. PubMed ID: 37642402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-translational modifications of EZH2 in cancer.
    Li Z; Li M; Wang D; Hou P; Chen X; Chu S; Chai D; Zheng J; Bai J
    Cell Biosci; 2020 Dec; 10(1):143. PubMed ID: 33308321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Advances in Post-translational Modifications and Endometriosis].
    Zhu JW; Xue Q
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Dec; 42(6):810-814. PubMed ID: 33423730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SUMOylation: A critical transcription modulator in plant cells.
    Han D; Lai J; Yang C
    Plant Sci; 2021 Sep; 310():110987. PubMed ID: 34315601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-translational modifications of FOXO family proteins (Review).
    Wang Z; Yu T; Huang P
    Mol Med Rep; 2016 Dec; 14(6):4931-4941. PubMed ID: 27779663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Applications of post-translational modifications of FoxO family proteins in biological functions.
    Zhao Y; Wang Y; Zhu WG
    J Mol Cell Biol; 2011 Oct; 3(5):276-82. PubMed ID: 21669942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional Regulation of PPARs through Post-Translational Modifications.
    Brunmeir R; Xu F
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allosteric regulation of protein 14-3-3ζ scaffold by small-molecule editing modulates histone H3 post-translational modifications.
    Wan YJ; Liao LX; Liu Y; Yang H; Song XM; Wang LC; Zhang XW; Qian Y; Liu D; Shi XM; Han LW; Xia Q; Liu KC; Du ZY; Jiang Y; Zhao MB; Zeng KW; Tu PF
    Theranostics; 2020; 10(2):797-815. PubMed ID: 31903151
    [No Abstract]   [Full Text] [Related]  

  • 37. A validated antibody panel for the characterization of tau post-translational modifications.
    Ercan E; Eid S; Weber C; Kowalski A; Bichmann M; Behrendt A; Matthes F; Krauss S; Reinhardt P; Fulle S; Ehrnhoefer DE
    Mol Neurodegener; 2017 Nov; 12(1):87. PubMed ID: 29157277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 modifications: exquisite decorations of the powerful guardian.
    Liu Y; Tavana O; Gu W
    J Mol Cell Biol; 2019 Jul; 11(7):564-577. PubMed ID: 31282934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-translational modification of human heat shock factors and their functions: a recent update by proteomic approach.
    Xu YM; Huang DY; Chiu JF; Lau AT
    J Proteome Res; 2012 May; 11(5):2625-34. PubMed ID: 22494029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Posttranslational Modifications of PD-L1 and Their Applications in Cancer Therapy.
    Hsu JM; Li CW; Lai YJ; Hung MC
    Cancer Res; 2018 Nov; 78(22):6349-6353. PubMed ID: 30442814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.